Phase III Data With Scar Therapy Still Distant, Renovo Draws A Suitor
This article was originally published in The Pink Sheet Daily
Executive Summary
Pivotal results not due until 2011 – and skin peel drug needs a makeover.
You may also be interested in...
Investor Sigma-Tau Takes Another Slice of RegeneRx Pie
Cosmeceuticals could bring revenue in 2010, but safer beauty space is no “free lunch,” says troubled biotech’s CEO.
Investor Sigma-Tau Takes Another Slice of RegeneRx Pie
Cosmeceuticals could bring revenue in 2010, but safer beauty space is no “free lunch,” says troubled biotech’s CEO.
PPD Buys Into Dermatology, Peels Off Cancer
Takeover of Magen for $14.5M adds early-stage compounds licensed from Lilly last year.